Patents by Inventor Anne Christensen

Anne Christensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs)
    Patent number: 7906491
    Abstract: The present invention relates to novel compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs). In particular, the present invention relates to cAMP analogues that specifically modulate the activity of Epacs. Examples of the compounds of the invention are substituted deoxyadenosine-cyclic monosphosphates. The invention further relates to pharmaceutical compositions comprising the novel compounds, and the use of the compounds in the treatment of diseases like cancer, chronic inflammation, thrombosis and/or type-2 diabetes mellitus in humans and/or animals.
    Type: Grant
    Filed: June 10, 2003
    Date of Patent: March 15, 2011
    Assignee: Univisitair Medisch Centrum Utrecht
    Inventors: John De Koning, Anne Christensen, Frank Schwede, Hans Gottfired Genieser, Stein Doskeland, Johannes Bos
  • Reduction of the transport capacity of a virtual concatenation group
    Patent number: 7616558
    Abstract: The transport capacity of a Virtual Concatenation Group (VCG) can be reduced under control of a Link Capacity Adjustment Scheme (LCAS). The VCG comprises link members, in which payload data are transmitted. A first control message comprising a fail message (RFAIL) for a link member is transmitted from sink to source, while the sink continues reception of payload data. On reception of the first control message at the source, a second control message is transmitted comprising a message (FDNU) indicating that payload data of the link member shall not be used, and transmission of payload data is discontinued. On reception of the second control message at the sink reception of payload data is discontinued, and the link member is removed. This allows a reduction of the transport capacity of a Virtual Concatenation Group to be performed in a hitless manner, even when initiated at the sink side.
    Type: Grant
    Filed: November 30, 2005
    Date of Patent: November 10, 2009
    Assignee: Tellabs Operations, Inc.
    Inventors: Anne Christensen, Flemming Gerdstrom
  • STABLE SOLID FORMULATION OF SERTINDOLE
    Publication number: 20070212412
    Abstract: The present invention relates to a pharmaceutical composition comprising sertindole and a protective agent absorbing radiation with a wavelenght below 400 nm. The present invention also relates to the use of sertindole for the preparation of a pharmaceutical composition comprising sertindole and a coating layer compsrising said protective agent, such as ironoxide, for the treatment of schizophrenia.
    Type: Application
    Filed: September 8, 2006
    Publication date: September 13, 2007
    Applicant: H. Lundbeck A/S
    Inventors: Flemming Olsen, Anne Christensen, Ken Liljegren
  • Reduction of the transport capacity of a virtual concatenation group
    Publication number: 20060140225
    Abstract: The transport capacity of a Virtual Concatenation Group (VCG) can be reduced under control of a Link Capacity Adjustment Scheme (LCAS). The VCG comprises link members, in which payload data are transmitted. A first control message comprising a fail message (RFAIL) for a link member is transmitted from sink to source, while the sink continues reception of payload data. On reception of the first control message at the source, a second control message is transmitted comprising a message (FDNU) indicating that payload data of the link member shall not be used, and transmission of payload data is discontinued. On reception of the second control message at the sink reception of payload data is discontinued, and the link member is removed. This allows a reduction of the transport capacity of a Virtual Concatenation Group to be performed in a hitless manner, even when initiated at the sink side.
    Type: Application
    Filed: November 30, 2005
    Publication date: June 29, 2006
    Applicant: Tellabs Operations, Inc.
    Inventors: Anne Christensen, Flemming Gerdstrom
  • Compounds for modulating the activity of exchange proteins directly activated by camp (epacs)
    Publication number: 20060100166
    Abstract: The present invention relates to novel compounds for modulating the activity of exchange proteins directly activated by cAMP (Epacs). In particular, the present invention relates to cAMP analogues that specifically modulate the activity of Epacs. The invention further relates to pharmaceutical compositions comprising the novel compounds, and the use of the compounds in the treatment of humans and/or animals.
    Type: Application
    Filed: June 10, 2003
    Publication date: May 11, 2006
    Applicant: KYLIX B.V.
    Inventors: John De Koning, Anne Christensen, Frank Schwede, Hans Genieser, Stein Doskeland, Johannes Bos